<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font27">the </span>
   <span class="font22">HEV </span>
   <span class="font22">for </span>
   <span class="font21">hepatitis </span>
   <span class="font18">with </span>
   <span class="font17">infection </span>
   <span class="font16">[]. </span>
   <span class="font16">virus </span>
   <span class="font14">chronic </span>
   <span class="font14">patients </span>
   <span class="font13">The </span>
   <span class="font13">liver </span>
   <span class="font13">from </span>
   <span class="font13">{background </span>
   <span class="font13">acute </span>
   <span class="font13">RNA </span>
   <span class="font12">has </span>
   <span class="font12">are </span>
   <span class="font12">margin </span>
   <span class="font12">ribavirin </span>
   <span class="font12">{border-style </span>
   <span class="font12">viral </span>
   <span class="font12">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">anti-HEV </span>
   <span class="font11">response </span>
   <span class="font11">transplant </span>
   <span class="font11">blood </span>
   <span class="font11">can </span>
   <span class="font11">detection </span>
   <span class="font11">have </span>
   <span class="font11">immunocompromised </span>
   <span class="font11">pregnancy </span>
   <span class="font11">pregnant </span>
   <span class="font11">IgM </span>
   <span class="font11">Med </span>
   <span class="font11">been </span>
   <span class="font11">treatment </span>
   <span class="font11">during </span>
   <span class="font11">study </span>
   <span class="font11">testing </span>
   <span class="font11">[â€¢â€¢]. </span>
   <span class="font11">among </span>
   <span class="font11">available </span>
   <span class="font11">IgG </span>
   <span class="font11">antibodies </span>
   <span class="font11">clinical </span>
   <span class="font11">genotype </span>
   <span class="font11">months </span>
   <span class="font11">tests </span>
   <span class="font11">was </span>
   <span class="font11">women </span>
   <span class="font11">[â€¢]. </span>
   <span class="font11">after </span>
   <span class="font11">disease </span>
   <span class="font11">organ </span>
   <span class="font11">that </span>
   <span class="font11">transmission </span>
   <span class="font11">vaccine </span>
   <span class="font11">assays </span>
   <span class="font11">but </span>
   <span class="font11">cause </span>
   <span class="font11">evidence </span>
   <span class="font11">failure </span>
   <span class="font11">not </span>
   <span class="font11">al. </span>
   <span class="font11">course </span>
   <span class="font11">severe </span>
   <span class="font11">usually </span>
   <span class="font11">virological </span>
   <span class="font11">weeks </span>
   <span class="font11">who </span>
   <span class="font10">Clin </span>
   <span class="font10">Hepatitis </span>
   <span class="font10">However, </span>
   <span class="font10">Infect </span>
   <span class="font10">any </span>
   <span class="font10">areas </span>
   <span class="font10">genotypes </span>
   <span class="font10">high </span>
   <span class="font10">management </span>
   <span class="font10">more </span>
   <span class="font10">px; </span>
   <span class="font10">recent </span>
   <span class="font10">sensitivity </span>
   <span class="font10">solid </span>
   <span class="font10">these </span>
   <span class="font10">{font-family </span>
   <span class="font10">â€" </span>
   <span class="font10">Also, </span>
   <span class="font10">HEV-infected </span>
   <span class="font10">Hepatol </span>
   <span class="font10">Virol </span>
   <span class="font10">acid </span>
   <span class="font10">amplification </span>
   <span class="font10">antigen </span>
   <span class="font10">capsid </span>
   <span class="font10">causes </span>
   <span class="font10">font-size </span>
   <span class="font10">immune </span>
   <span class="font10">its </span>
   <span class="font10">levels </span>
   <span class="font10">may </span>
   <span class="font10">negative </span>
   <span class="font10">option </span>
   <span class="font10">patient </span>
   <span class="font10">replication </span>
   <span class="font10">showed </span>
   <span class="font10">specificity </span>
   <span class="font10">such </span>
   <span class="font10">sustained </span>
   <span class="font10">therapy </span>
   <span class="font10">upon </span>
   <span class="font10">â€"% </span>
   <span class="font10">Dis </span>
   <span class="font10">Gastroenterol </span>
   <span class="font10">against </span>
   <span class="font10">assay </span>
   <span class="font10">cases </span>
   <span class="font10">diagnosis </span>
   <span class="font10">double; </span>
   <span class="font10">due </span>
   <span class="font10">infection, </span>
   <span class="font10">infection. </span>
   <span class="font10">infections </span>
   <span class="font10">kits </span>
   <span class="font10">mostly </span>
   <span class="font10">other </span>
   <span class="font10">parts </span>
   <span class="font10">recipients </span>
   <span class="font10">recommends </span>
   <span class="font10">research </span>
   <span class="font10">screening </span>
   <span class="font10">test </span>
   <span class="font10">through </span>
   <span class="font10">which </span>
   <span class="font10">while </span>
   <span class="font10">EASL </span>
   <span class="font10">Engl </span>
   <span class="font10">Liver </span>
   <span class="font10">Microbiol </span>
   <span class="font10">ORF </span>
   <span class="font10">Rev </span>
   <span class="font10">There </span>
   <span class="font10">This </span>
   <span class="font10">also </span>
   <span class="font10">another </span>
   <span class="font10">antigenic </span>
   <span class="font10">antiviral </span>
   <span class="font10">article </span>
   <span class="font10">associated </span>
   <span class="font10">before </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">caused </span>
   <span class="font10">considered </span>
   <span class="font10">developed </span>
   <span class="font10">different </span>
   <span class="font10">drug </span>
   <span class="font10">efficacy </span>
   <span class="font10">either </span>
   <span class="font10">epidemiological </span>
   <span class="font10">first </span>
   <span class="font10">form </span>
   <span class="font10">further </span>
   <span class="font10">including </span>
   <span class="font10">indirect </span>
   <span class="font10">interferon </span>
   <span class="font10">lower </span>
   <span class="font10">non-B </span>
   <span class="font10">out </span>
   <span class="font10">patients. </span>
   <span class="font10">recommended </span>
   <span class="font10">responsible </span>
   <span class="font10">results </span>
   <span class="font10">solid; </span>
   <span class="font10">suspected </span>
   <span class="font10">than </span>
   <span class="font10">therapeutic </span>
   <span class="font10">women, </span>
   <span class="font10">world, </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">ALF </span>
   <span class="font10">Health </span>
   <span class="font10">Hence, </span>
   <span class="font10">Hyg </span>
   <span class="font10">Since </span>
   <span class="font10">These </span>
   <span class="font10">Trop </span>
   <span class="font10">administered </span>
   <span class="font10">animal </span>
   <span class="font10">antibody </span>
   <span class="font10">based </span>
   <span class="font10">between </span>
   <span class="font10">bold </span>
   <span class="font10">both </span>
   <span class="font10">case </span>
   <span class="font10">clinically </span>
   <span class="font10">commercially </span>
   <span class="font10">could </span>
   <span class="font10">courier; </span>
   <span class="font10">detected </span>
   <span class="font10">disease. </span>
   <span class="font10">dose </span>
   <span class="font10">early </span>
   <span class="font10">em; </span>
   <span class="font10">endemic </span>
   <span class="font10">enveloped </span>
   <span class="font10">established </span>
   <span class="font10">even </span>
   <span class="font10">found </span>
   <span class="font10">host </span>
   <span class="font10">human </span>
   <span class="font10">hyperendemic </span>
   <span class="font10">intrauterine </span>
   <span class="font10">mortality </span>
   <span class="font10">nearly </span>
   <span class="font10">non-a, </span>
   <span class="font10">orf </span>
   <span class="font10">outcomes </span>
   <span class="font10">phase </span>
   <span class="font10">polymerase </span>
   <span class="font10">prevalence </span>
   <span class="font10">proteins </span>
   <span class="font10">pt;} </span>
   <span class="font10">rates </span>
   <span class="font10">recombinant </span>
   <span class="font10">reported </span>
   <span class="font10">ribavirin-resistant </span>
   <span class="font10">risk </span>
   <span class="font10">serology </span>
   <span class="font10">should </span>
   <span class="font10">shows </span>
   <span class="font10">suggests </span>
   <span class="font10">tested </span>
   <span class="font10">their </span>
   <span class="font10">two </span>
   <span class="font10">used </span>
   <span class="font10">via </span>
   <span class="font10">vitro </span>
   <span class="font10">water </span>
   <span class="font10">years </span>
   <span class="font10">~â€‰Â </span>
   <span class="font10">â€"Â </span>
  </p>
 </body>
</html>
